Research Article

Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry

Table 2

Bead catheter infusion outcomes.

𝑁 = 3 0 total treatments

Number of bead coursesMedian 2 (range 1–5)
Technical success97%
Dosage delivered (median, range)75 mg (19–200)
Total hepatic dose exposure150 (0–458)
 1150 (0–200)
 2150 (79–190)
 3325
 >3458
Bead Size Utilized
 100–30024
 300–5005
 500–7001
Complications14%
Extrahepatic infusion0
Hematologic changes
 WBCβˆ’1.9 (βˆ’9994.4–9991.8)
 HGB0.1 (βˆ’9989.1–9987.5)
 Bilirubin0 (βˆ’9998.7–9998.8)